Abdominal Distension and Escherichia coli Peritonitis in Mice Lacking Myeloid Differentiation Factor 88 |
| |
Authors: | Linda K Johnson Antin YN Widi Serrin Rowarth Alan G Baxter |
| |
Affiliation: | 1.College of Public Health, Medical and Veterinary Science, James Cook University, Townsville, Queensland, Australia;2.Faculty of Veterinary Medicine, Nusa Cendana University, Kupang, East Nusa Tenggara, Indonesia; and;3.Comparative Genomics Centre, James Cook University, Townsville, Queensland, Australia |
| |
Abstract: | Here we describe the gross and microscopic findings of naturally occurring, β-hemolytic Escherichia coli peritonitis in B6.129-Myd88tm1Aki male and female mice. Over approximately 5 mo, 10 homozygous mutant mice deficient in myeloid differentiation factor 88 (C57BL/6 strain; male and female) that had not been used in research protocols developed rapid-onset abdominal swelling associated with copious viscous ascites. Each mouse developed an anterior peritonitis, primarily involving the parietal peritoneum and the visceral surface of the spleen, liver, diaphragm, and stomach. Inflammation was confined to the organ surfaces, with no indication of septicemia or grossly apparent gastrointestinal perforation or other tissue compromise that would initiate peritonitis. Peritonitis was likely attributable to compromised antibacterial innate immunity; cohoused, similarly immunodeficient littermates did not develop similar clinical signs. An unusual finding in all cases was mesothelial cell hyperplasia and hypertrophy. Although the underlying innate immune deficiency accounts for much of the observed pathology, the remarkable mesothelial cell morphology and the episodic nature of the peritonitis in some littermates and not others remain unexplained.Abbreviations: MyD88, myeloid differentiation response 88; TLR, Toll-like receptorMice deficient in myeloid differentiation factor 88 (myD88) are commonly studied in immunologic research as models of various diseases, including inflammatory bowel disease and diabetes.2,3 MyD88 is a key signal transduction molecule for most of the Toll-like receptors (TLR) and IL1 family receptors, initiating cytokine release essential for effective innate immunity.18 The loss of this adapter protein impairs production of IL1, IL6, IL18, macrophage inhibitory proteins 1 and 2, and various chemokines.1,12,14 Knockout mutant mice are especially susceptible to gram-negative bacteria, because TLR4, which triggers signaling through MyD88, mediates responses to LPS.7,17 These immunologic mutants are common in research animal colonies, but their development of clinical signs and lesions consistent with Escherichia coli peritonitis, which arose at different times and affected only some of the immunodeficient mice, was previously unknown. |
| |
Keywords: | |
|
|